Quick Answer
SBC Medical Group Holdings Inc reported Cash and Equivalents of $163.77 million for fiscal year 2025.
SBC Medical Group Holdings Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $163.77M | +31.0% |
| 2024 | $125.04M | +21.4% |
| 2023 | $103.02M | +21117.2% |
| 2022 | $485.6K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $127.43M | -7.3% | -16.6% |
| June 30, 2025 | $152.74M | — | +15.7% |
| March 31, 2025 | $132.06M | — | +5.6% |
| December 31, 2024 | $125.04M | +21.4% | -9.0% |
| September 30, 2024 | $137.39M | — | +33.4% |
| December 31, 2023 | $103.02M | — | +17663.5% |
| September 30, 2022 | $580.0K | — | +223.2% |
| June 30, 2022 | $179.4K | — | — |
- SBC Medical Group Holdings Inc showed an increase of +31.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, SBC Medical Group Holdings Inc’s cash and equivalents has grown by 33628.6% (from $485.6 thousand to $163.77 million).
- The most recent figure is from SBC Medical Group Holdings Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: